These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 26979937)
1. Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model. Savari S; Chandrashekar NK; Osman J; Douglas D; Bellamkonda K; Jönsson G; Juhas M; Greicius G; Pettersson S; Sjölander A Carcinogenesis; 2016 May; 37(5):491-9. PubMed ID: 26979937 [TBL] [Abstract][Full Text] [Related]
2. Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer. Osman J; Savari S; Chandrashekar NK; Bellamkonda K; Douglas D; Sjölander A Oncotarget; 2017 May; 8(21):34773-34786. PubMed ID: 28410235 [TBL] [Abstract][Full Text] [Related]
3. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis. Li Q; Ishikawa TO; Oshima M; Taketo MM Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028 [TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin. Rajamanickam S; Velmurugan B; Kaur M; Singh RP; Agarwal R Cancer Res; 2010 Mar; 70(6):2368-78. PubMed ID: 20215518 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice. Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636 [TBL] [Abstract][Full Text] [Related]
7. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063 [TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression. Yekkala K; Baudino TA Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987 [TBL] [Abstract][Full Text] [Related]
10. CD24 knockout prevents colorectal cancer in chemically induced colon carcinogenesis and in APC(Min)/CD24 double knockout transgenic mice. Naumov I; Zilberberg A; Shapira S; Avivi D; Kazanov D; Rosin-Arbesfeld R; Arber N; Kraus S Int J Cancer; 2014 Sep; 135(5):1048-59. PubMed ID: 24500912 [TBL] [Abstract][Full Text] [Related]
11. Nrf2 knockout enhances intestinal tumorigenesis in Apc(min/+) mice due to attenuation of anti-oxidative stress pathway while potentiates inflammation. Cheung KL; Lee JH; Khor TO; Wu TY; Li GX; Chan J; Yang CS; Kong AN Mol Carcinog; 2014 Jan; 53(1):77-84. PubMed ID: 22911891 [TBL] [Abstract][Full Text] [Related]
12. Evidence against dominant negative mechanisms of intestinal polyp formation by Apc gene mutations. Oshima M; Oshima H; Kobayashi M; Tsutsumi M; Taketo MM Cancer Res; 1995 Jul; 55(13):2719-22. PubMed ID: 7796392 [TBL] [Abstract][Full Text] [Related]
13. A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression. Zeineldin M; Cunningham J; McGuinness W; Alltizer P; Cowley B; Blanchat B; Xu W; Pinson D; Neufeld KL Oncogene; 2012 May; 31(19):2423-37. PubMed ID: 21996741 [TBL] [Abstract][Full Text] [Related]
15. Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/+) mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. Tanaka T; Kohno H; Suzuki R; Hata K; Sugie S; Niho N; Sakano K; Takahashi M; Wakabayashi K Int J Cancer; 2006 Jan; 118(1):25-34. PubMed ID: 16049979 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers. Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529 [TBL] [Abstract][Full Text] [Related]
17. The armadillo repeat domain of Apc suppresses intestinal tumorigenesis. Crist RC; Roth JJ; Baran AA; McEntee BJ; Siracusa LD; Buchberg AM Mamm Genome; 2010 Oct; 21(9-10):450-7. PubMed ID: 20886217 [TBL] [Abstract][Full Text] [Related]
18. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta. Liu HP; Gao ZH; Cui SX; Sun DF; Wang Y; Zhao CR; Lou HX; Qu XJ PLoS One; 2012; 7(3):e33243. PubMed ID: 22432006 [TBL] [Abstract][Full Text] [Related]
20. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice. Song J; Sohn KJ; Medline A; Ash C; Gallinger S; Kim YI Cancer Res; 2000 Jun; 60(12):3191-9. PubMed ID: 10866310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]